This content is from: Capital Markets
No respite for buyside on HY terms
Covenant quality has eroded substantially over the past year as fewer deals have come to market, leaving investors frustrated
To access our in-house intelligence please request a trial here.
Read this article – and more – for a 30 day period.
REQUEST ACCESSAre you already an IFLR subscriber? Login here